PAVMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
PAVmed Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$2.25−0.16 (-6.64%)
Close on Oct 19, 2026
- Market cap
- $14.11M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$12.96 (−85.21%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsSplit
PAVmed Inc. saw revenue fall 89.0% to $112.00K over the twelve months to Jun 30, 2026. Free cash flow was -$7.78M.
Revenue
$112.00K
-89.0% vs. a year earlier
Operating income
-$26.70M
TTM Q2 2026
Free cash flow
-$7.78M
TTM Q2 2026
EPS, diluted
-$5.63
-137.8% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $14.11M
- P/E ratio
- –
- Price to sales
- 125.95
- Price to book
- 0.40
- Dividend yield
- –
- Free cash flow yield
- -55.17%
Fundamentals
- Revenue
- $112.00K
- Net income
- -$12.09M
- EPS, diluted
- -$5.63
- Free cash flow
- -$7.78M
- Book value per share
- $5.59
- Diluted shares
- 6M
Twelve years at a glance
Fiscal years 2014 to 2025 and trailing twelve months, USD
Revenue
$112.00K-89.0% YoY
Gross profit
-$247.00K
Operating income
-$26.70M
Net income
-$12.09M-116.6% YoY
EPS, diluted
–
Free cash flow
-$7.78M
Reported periodTrailing twelve months